Entry |
|
Name |
Piclidenoson (USAN/INN) |
Formula |
C18H19IN6O4
|
Exact mass |
510.0513
|
Mol weight |
510.29
|
Structure |
|
Simcomp |
|
Efficacy |
Anti-inflammatory, Adenosine A3 receptor agonist |
Comment |
Treatment of dry eye, psoriasis, glaucoma, rheumatoid arthritis and osteoarthritis of the knee
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA3
D10971 Piclidenoson (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 29
1 N4y N 18.8754 -15.3680
2 C8y C 19.8711 -16.1990
3 C1y C 17.5786 -15.7847
4 C8x C 19.4773 -14.0122
5 C8y C 21.1871 -15.4068
6 N5x N 19.8747 -17.6311
7 O2x O 16.4345 -14.9339
8 C1y C 17.1503 -17.0403
9 N5x N 20.9256 -14.1513
10 C8y C 22.3871 -16.0712
11 C8x C 21.1410 -18.3426
12 C1y C 15.3314 -15.7260
13 C1y C 15.7598 -17.0403
14 O1a O 17.5610 -18.3780
15 N5x N 22.4140 -17.5701
16 N1b N 23.5665 -15.3547
17 O1a O 15.3137 -18.3722
18 C5a C 14.0139 -15.2945
19 N1b N 12.7920 -15.9692
20 O5a O 13.9715 -13.9018
21 C1a C 11.5874 -15.2431
22 C1b C 24.8014 -16.0317
23 C8y C 25.9908 -15.3272
24 C8x C 27.2033 -16.0272
25 C8y C 28.4157 -15.3272
26 C8x C 28.4157 -13.9272
27 C8x C 27.2033 -13.2272
28 C8x C 25.9908 -13.9272
29 X I 29.6326 -16.0298
BOND 32
1 1 2 1
2 3 1 1 #Up
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 7 12 1
12 8 13 1
13 8 14 1 #Down
14 10 15 2
15 10 16 1
16 13 17 1 #Down
17 5 9 1
18 11 15 1
19 12 13 1
20 12 18 1 #Up
21 18 19 1
22 18 20 2
23 19 21 1
24 16 22 1
25 22 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
32 25 29 1
|